DRREDDY News Today

Dr Reddys Laboratories Ltd Share Price

DRREDDY

NSE

CMP as on 29-Sep-23 12:28
₹ 5,617

icon 187.80 | 3.46%

Open
₹ 5,469
Turnover(lac)
₹ 16,928
Prev. Close
₹ 5,429.10
Day's Vol (shares)
₹ 301,375
Day's Vol (shares)
₹ 5,453.25         ₹ 5,630.00

BSE

CMP as on 29-Sep-23 12:26
₹ 5,615

icon 189.00 | 3.48%

Open
₹ 5,430
Turnover(lac)
₹ 465
Prev. Close
₹ 5,425.55
Day's Vol (shares)
₹ 6,384
Day's Vol (shares)
₹ 5,430.05         ₹ 5,629.55

FUTURE


Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
Image not found

According to a BSE notification dated September 28, it will be involved in the importing, warehousing, distribution, and exportation of pharmaceuticals.

  • 29 September, 2023
  • 12:20 PM
  • less than a minute
Image not found

The company has fixed the price band at Rs 133 to Rs 140 per equity share

  • 29 September, 2023
  • 12:03 PM
  • less than a minute
Blog Image

Dr Reddy's was trying to expand its footprint in numerous developing categories such as nutraceuticals.

  • 29 September, 2023
  • 9:20 AM
  • less than a minute
Image not found

The price band for the offer, which closes on October 3, is Rs 133-140 per share.

  • 28 September, 2023
  • 12:52 PM
  • less than a minute
Image not found

A 51% stake in TCNS Clothing has been acquired by Aditya Birla Fashion Retail Ltd (ABFRL), making it a promoter of the women's clothing company.

  • 27 September, 2023
  • 2:36 PM
  • less than a minute
Blog Image

The company intends to raise Rs 152 crore from the offer with fresh issue of equity shares and no element of offer for sale

  • 27 September, 2023
  • 12:18 PM
  • less than a minute
Blog Image

The price band for this IPO is set at Rs 133-140 per share.

  • 26 September, 2023
  • 9:48 PM
  • less than a minute
Image not found

A full maintenance contract with a post-warranty cost of Rs 43.22 crore, including GST, is included in the contract.

  • 26 September, 2023
  • 12:41 PM
  • less than a minute
Image not found

Excluding deal-related amortization expenses, the Biogen Biosimilars deal could add 24% and 29% to Dr. Reddy’s FY24 revenue and profits on a pro-forma basis.

  • 26 September, 2023
  • 11:10 AM
  • less than a minute
Blog Image

Valiant Laboratories is expected to make its debut on the BSE and NSE on October 9, 2023.

  • 23 September, 2023
  • 10:20 PM
  • less than a minute